Public Health Service Act, Delegation of Authority, 31870 [2019-14255]
Download as PDF
<![CDATA[
31870
Federal Register / Vol. 84, No. 128 / Wednesday, July 3, 2019 / Notices
Regulations.gov. An agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently valid Office of Management
and Budget control number.
Dated: June 25, 2019.
David A. Shive,
Chief Information Officer.
[FR Doc. 2019–14217 Filed 7–2–19; 8:45 am]
BILLING CODE 6820–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for QA to QI
LLC
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ has accepted a
notification of voluntary relinquishment
from QA to QI LLC, PSO number P0091,
of its status as a PSO, and has delisted
the PSO accordingly.
DATES: The delisting was effective at
12:00 Midnight ET (2400) on June 15,
2019.
SUMMARY:
The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
jspears on DSK30JT082PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
19:23 Jul 02, 2019
Jkt 247001
Background
The Patient Safety Act, 42 U.S.C.
299b–21 to 299b–26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety events.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from QA to QI LLC, to voluntarily
relinquish its status as a PSO.
Accordingly, QA to QI LLC, P0091, was
delisted effective at 12:00 Midnight ET
(2400) on June 15, 2019.
QA to QI LLC has patient safety work
product (PSWP) in its possession. The
PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019–14215 Filed 7–2–19; 8:45 am]
BILLING CODE 4160–90–P
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Public Health Service Act, Delegation
of Authority
Notice is hereby given that I have
delegated to the Director, Center for
Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC),
and the Director, Human Resources
Office (HRO), CDC, without authority to
redelegate, the authority vested in the
Director, CDC/Administrator, Agency
for Toxic Substances and Disease
Registry (ATSDR), under Section 317F,
Title III of the Public Health Service
Act, [42 U.S.C. 247b–7, as amended, to
carry out a loan repayment program in
accordance with Section 317F,
guidelines and procedures issued by the
Director, CDC/Administrator, ATSDR,
CSELS, HRO, and all other applicable
federal laws, regulations and policies, in
conjunction with the Future Leaders in
Infectious and Global Health Threats
(FLIGHT) program.
This delegation became effective on
June 26, 2019.
Robert R. Redfield,
Director, Centers for Disease Control and
Prevention, Administrator, Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2019–14255 Filed 7–2–19; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10556]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
SUMMARY:
E:\FR\FM\03JYN1.SGM
03JYN1
]]>Agencies
[Federal Register Volume 84, Number 128 (Wednesday, July 3, 2019)]
[Notices]
[Page 31870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14255]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Public Health Service Act, Delegation of Authority
Notice is hereby given that I have delegated to the Director,
Center for Surveillance, Epidemiology and Laboratory Services (CSELS),
Centers for Disease Control and Prevention (CDC), and the Director,
Human Resources Office (HRO), CDC, without authority to redelegate, the
authority vested in the Director, CDC/Administrator, Agency for Toxic
Substances and Disease Registry (ATSDR), under Section 317F, Title III
of the Public Health Service Act, [42 U.S.C. 247b-7, as amended, to
carry out a loan repayment program in accordance with Section 317F,
guidelines and procedures issued by the Director, CDC/Administrator,
ATSDR, CSELS, HRO, and all other applicable federal laws, regulations
and policies, in conjunction with the Future Leaders in Infectious and
Global Health Threats (FLIGHT) program.
This delegation became effective on June 26, 2019.
Robert R. Redfield,
Director, Centers for Disease Control and Prevention, Administrator,
Agency for Toxic Substances and Disease Registry.
[FR Doc. 2019-14255 Filed 7-2-19; 8:45 am]
BILLING CODE 4160-18-P
